<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04958304</url>
  </required_header>
  <id_info>
    <org_study_id>mRNA-1273-P902</org_study_id>
    <nct_id>NCT04958304</nct_id>
  </id_info>
  <brief_title>Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study</brief_title>
  <official_title>Moderna mRNA-1273 Observational Pregnancy Outcome Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ModernaTX, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ModernaTX, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main goal of this study is to evaluate the outcomes of pregnancy in females exposed to&#xD;
      the Moderna COVID-19 vaccine (mRNA-1273) during pregnancy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Moderna COVID-19 Vaccine Pregnancy Registry will collect and analyze information on the&#xD;
      potential impact of exposure to the Moderna COVID-19 vaccine on pregnancy and birth outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">January 6, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 9, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>21 Months</target_duration>
  <primary_outcome>
    <measure>Number of Participants Having Infants With Suspected Major and Minor Congenital Malformations</measure>
    <time_frame>Up to 1 year of infant age</time_frame>
    <description>Major malformations are those that have significant medical, social or cosmetic consequences, and typically require surgical intervention or are life-threatening (for example, cleft lip, spina bifida).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Any Pregnancy Complications</measure>
    <time_frame>From end of first trimester (approximately 14 weeks) up to mid-third trimester (approximately 34 weeks)</time_frame>
    <description>Pregnancy complications may include preeclampsia, eclampsia, pregnancy-induced hypertension, antenatal bleeding, preterm labor, gestational diabetes, dysfunctional labor, premature rupture of membranes, placenta previa, postpartum hemorrhage, small-for-gestational-age (SGA) fetus and intrauterine growth restriction (IUGR), and non-reassuring fetal status.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Any Pregnancy Outcomes</measure>
    <time_frame>Approximately 4 weeks after expected date of delivery (EDD)</time_frame>
    <description>Pregnancy outcomes may include spontaneous abortions, fetal death or stillbirth, live birth, elective or therapeutic pregnancy terminations, preterm birth, ectopic pregnancies, molar pregnancies, maternal death, and COVID-19 diagnosis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Infant Outcomes</measure>
    <time_frame>Up to 1 year of infant age</time_frame>
    <description>Infant outcomes may include minor congenital malformations, size of gestational age, low birth weight, size for age, failure to thrive, hospitalization of infants, neonatal death, perinatal death, neonatal encephalopathy, respiratory distress in the newborn, neonatal/infant infection, infant death, and infant developmental milestones.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>SARS-CoV-2</condition>
  <arm_group>
    <arm_group_label>Moderna COVID-19 Vaccine in Pregnant Women</arm_group_label>
    <description>The Moderna COVID-19 Vaccine Pregnancy Registry will collect primary data from pregnant women who have received the Moderna COVID-19 vaccine and their healthcare providers (HCPs).</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Women who have been exposed the Moderna COVID-19 vaccine during the 28 days prior to their&#xD;
        LMP or at any time during pregnancy are eligible for this exposed cohort.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Currently pregnant&#xD;
&#xD;
          -  The outcome of pregnancy (that is, pregnancy loss or live birth) must not be known at&#xD;
             entry.&#xD;
&#xD;
          -  Agrees to electronically sign the release of medical information form permitting the&#xD;
             study to contact her HCPs (for example, primary care provider [PCP], obstetrician,&#xD;
             nurse midwife) and the infant's HCP (for example, pediatrician) for medical&#xD;
             information.&#xD;
&#xD;
          -  Received the Moderna COVID-19 vaccine at any point from 28 days prior to last&#xD;
             menstrual period (LMP) throughout pregnancy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participant has received any other COVID-19 vaccines at any point from 28 days prior&#xD;
             to LMP throughout pregnancy.&#xD;
&#xD;
          -  Women currently participating in another investigational device or drug study,&#xD;
             currently taking an investigational medicinal product, or having taken an&#xD;
             investigational product within 28 days prior to LMP or during pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Moderna Clinical Trials</last_name>
    <phone>877-913-3286</phone>
    <email>clinicaltrials@modernatx.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>IQVIA Call Center for United States and Canada</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27703</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 9, 2021</study_first_submitted>
  <study_first_submitted_qc>July 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2021</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mRNA-1273</keyword>
  <keyword>mRNA-1273 vaccine</keyword>
  <keyword>SARS-CoV-2</keyword>
  <keyword>SARS-CoV-2 Vaccine</keyword>
  <keyword>Coronavirus</keyword>
  <keyword>Virus Diseases</keyword>
  <keyword>Messenger RNA</keyword>
  <keyword>COVID-19</keyword>
  <keyword>COVID-19 Vaccine</keyword>
  <keyword>Moderna</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

